Mark Sherman

425 total citations
11 papers, 113 citations indexed

About

Mark Sherman is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Mark Sherman has authored 11 papers receiving a total of 113 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Mark Sherman's work include Lipoproteins and Cardiovascular Health (4 papers), Cardiovascular Health and Disease Prevention (2 papers) and Heart Rate Variability and Autonomic Control (2 papers). Mark Sherman is often cited by papers focused on Lipoproteins and Cardiovascular Health (4 papers), Cardiovascular Health and Disease Prevention (2 papers) and Heart Rate Variability and Autonomic Control (2 papers). Mark Sherman collaborates with scholars based in Canada, United States and Poland. Mark Sherman's co-authors include Kaberi Dasgupta, Ellen Rosenberg, Lawrence Joseph, Stella S. Daskalopoulou, Rémi Rabasa‐Lhoret, Luc Trudeau, Deborah Chan, Simon Bacon, Alexandra B. Cooke and Jacques Genest and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Biological Psychiatry and The American Journal of Cardiology.

In The Last Decade

Mark Sherman

10 papers receiving 107 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Sherman Canada 6 47 35 28 27 21 11 113
Kathleen M. McClain United States 10 75 1.6× 38 1.1× 9 0.3× 14 0.5× 16 0.8× 22 222
Marie-Josiane Ntsama Essomba Cameroon 6 80 1.7× 16 0.5× 23 0.8× 9 0.3× 18 0.9× 21 183
Ingemar Lönnberg Sweden 9 22 0.5× 21 0.6× 46 1.6× 101 3.7× 9 0.4× 13 179
Maria Wołyniec Poland 9 44 0.9× 9 0.3× 54 1.9× 23 0.9× 14 0.7× 25 170
C. Bustos Chile 4 12 0.3× 23 0.7× 14 0.5× 29 1.1× 8 0.4× 5 83
Angelika Wientzek Germany 6 69 1.5× 25 0.7× 9 0.3× 8 0.3× 7 0.3× 8 182
А. С. Алиева Russia 8 20 0.4× 42 1.2× 26 0.9× 93 3.4× 7 0.3× 44 192
KG Parhofer Germany 7 31 0.7× 52 1.5× 62 2.2× 26 1.0× 24 1.1× 15 165
Ahmed Mustafa Rashid Pakistan 8 44 0.9× 27 0.8× 54 1.9× 69 2.6× 6 0.3× 34 192

Countries citing papers authored by Mark Sherman

Since Specialization
Citations

This map shows the geographic impact of Mark Sherman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Sherman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Sherman more than expected).

Fields of papers citing papers by Mark Sherman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Sherman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Sherman. The network helps show where Mark Sherman may publish in the future.

Co-authorship network of co-authors of Mark Sherman

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Sherman. A scholar is included among the top collaborators of Mark Sherman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Sherman. Mark Sherman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Brown, Leslie, Isabelle L. Ruel, Alexis Baass, et al.. (2024). Sex differences in the presentation, treatment and outcomes of patients with homozygous familial hypercholesterolemia. Journal of clinical lipidology. 18(2). e189–e196. 3 indexed citations
2.
Brown, Leslie, Isabelle L. Ruel, Alexis Baass, et al.. (2023). Homozygous Familial Hypercholesterolemia in Canada. JACC Advances. 2(3). 100309–100309. 5 indexed citations
3.
Gupta, Nisha, et al.. (2023). Molar Pregnancy–Induced Hyperthyroidism: The Importance of Early Recognition and Timely Preoperative Management. JCEM Case Reports. 1(6). luad129–luad129. 2 indexed citations
4.
Brown, Leslie, Isabelle L. Ruel, Alexis Baass, et al.. (2023). Design, Rationale, and Preliminary Results of the Canadian Homozygous Familial Hypercholesterolemia Registry: 2008 to 2022 Update. Canadian Journal of Health Technologies. 3(2). 2 indexed citations
5.
Jones, Daniel W., et al.. (2021). Vasoactive intestinal peptide producing pheochromocytoma and intracardiac thrombosis. Rare Tumors. 13. 734599984–734599984. 1 indexed citations
6.
AlTurki, Ahmed, Jingxian Ni, J.‐C. Tardif, et al.. (2020). CONTEMPORARY RISK FACTORS FOR CARDIOVASCULAR OUTCOMES AMONG MEN AND WOMEN - INSIGHTS FROM THE CARTAGENE STUDY. Canadian Journal of Cardiology. 36(10). S18–S18.
7.
AlTurki, Ahmed, Marie‐Pierre Dubé, Lucy Vieira, et al.. (2019). Meta-analysis of Randomized Controlled Trials Assessing the Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies on Mortality and Cardiovascular Outcomes. The American Journal of Cardiology. 124(12). 1869–1875. 17 indexed citations
8.
Dasgupta, Kaberi, Ellen Rosenberg, Lawrence Joseph, et al.. (2017). Carotid femoral pulse wave velocity in type 2 diabetes and hypertension. Journal of Hypertension. 35(5). 1061–1069. 10 indexed citations
9.
Dasgupta, Kaberi, Ellen Rosenberg, Lawrence Joseph, et al.. (2017). Physician step prescription and monitoring to improve ARTERial health ( SMARTER ): A randomized controlled trial in patients with type 2 diabetes and hypertension. Diabetes Obesity and Metabolism. 19(5). 695–704. 51 indexed citations
10.
Marcil, Michel, et al.. (2004). Is the Decreased High-Density Lipoprotein Cholesterol in the Metabolic Syndrome Due to Cellular Lipid Efflux Defect?. The Journal of Clinical Endocrinology & Metabolism. 89(2). 761–764. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026